Results: Existing literature reports application of 2,154 single-patient trials in 108 studies for diverse clinical conditions; various recent
commentaries advocate for wider application of such trials in clinical decision making. Preliminary evidence from several recent pilot acceptability
studies suggests that single-patient trials have the potential for widespread acceptance by patients and clinicians as an effective
modality for increasing the therapeutic precision. Bayesian and adaptive statistical methods hold promise for increasing the informational
yield of single-patient trials while reducing participant burden, but are not widely used. Personalized applications of single-patient trials can
be enhanced through further development and application of methodologies on adaptive trial design, stopping rules, network meta-analysis,
washout methods, and methods for communicating trial findings to patients and clinicians.